Uzuakoli Leprosy Colony in Abia State has not received government funding since 2009, surviving instead on donations from churches and foreign NGOs while over 3,500 Nigerians are diagnosed with leprosy annually. The centre, established by Methodist missionaries in 1931 and once the foremost leprology facility in Africa, now stands as a monument to institutional collapse that epidemiologists say puts an entire generation at risk.
Nigeria recorded 2,425 new leprosy cases in 2023, with one in every ten patients arriving at clinics bearing Grade 2 disability—permanent, visible deformity that early detection would have prevented. In the Northeast, the crisis deepens: 87.7 per cent of newly diagnosed patients in Adamawa State and 81 per cent in Borno present with Grade 2 disability. These figures reveal a detection system in freefall. Nationwide, roughly 9.9 per cent of new cases involve children under 15, a statistic that signals active disease transmission in communities where leprosy should have vanished decades ago.
The human cost weighs heaviest on those already treated. A 2024 study of leprosy settlements across Nigeria found that 94.3 per cent of residents reported very poor quality of life. More than 60 per cent experienced stigma severe enough to damage their daily functioning and ability to earn a living. These are people who completed treatment, are no longer infectious, yet remain locked out of society and employment because the rehabilitation systems meant to restore them simply do not exist. Uzuakoli and 60 other settlements across the country receive no funding for physiotherapy, vocational training, or dignified housing. They depend instead on faith groups, the Leprosy Mission Nigeria, and German and Belgian NGOs that pay for drugs but cannot shoulder the broader burden of restoration.
This abandonment follows a political sleight of hand. Nigeria achieved formal leprosy elimination in 1998, defined as fewer than one case per 10,000 population. The government declared victory and scaled back the national programme. The milestone was announced and promptly forgotten. What remained was a hollow system where patients continued arriving but the infrastructure to care for them, detect new cases early, and rehabilitate the disabled simply withered away.
Fix this, health experts say, requires three urgent steps. The National Tuberculosis and Leprosy Control Programme must receive adequate funding and staffing to launch active case-finding campaigns in high-burden states and conflict-affected zones where disability rates have become a national embarrassment. Uzuakoli and other settlements must receive direct capital investment for rehabilitation facilities, not promises. Second, treatment cannot end at the clinic door. Patients need skills training, cooperative farming arrangements, and access to microcredit so they can rebuild livelihoods without facing the stigma that currently leaves them destitute. Third, the 10 per cent child case rate demands emergency response. It is not a statistic. It is proof that leprosy is still spreading in Nigerian communities and that a generation is being failed before it begins.
Abia State Governor Alex Otti's administration, which has invested in health reforms elsewhere, must extend that commitment to Uzuakoli and set a template the rest of the nation should follow. Nigeria pioneered leprosy treatment in Africa from this very centre. It can reclaim that position. Doing so requires money, will, and the refusal to let patients treated for a curable disease be abandoned to permanent poverty and rejection.
